68
Participants
Start Date
October 27, 2022
Primary Completion Date
September 25, 2024
Study Completion Date
September 30, 2024
Bilevel Erector spinae plane block
Patients will receive bilevel erector spinae plane block with bupivacaine
Bilateral Erector spinae plane block with dexamethasone
Patients will receive bilevel erector spinae plane block with bupivacaine and dexamethasone
Bilateral Erector spinae plane block with dexmedetomidine
Patients will receive bilevel erector spinae plane block with bupivacaine and dexmedetomidine
Intravenous morphine
Intravenous morphine 0.1 mg/kg
Walaa Y Elsabeeny, Cairo
National Cancer Institute, Egypt
OTHER